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 Abstract 
The circadian clock organizes biochemical and physiological processes of an organism in a temporal fashion. This tempo-
ral organization is crucial to avoid interference of processes that have adverse effects on each other. Thus, disruption of 
temporal organization can lead to health problems and behavioral disorders related to mood alterations. To alleviate the 
consequences of a disrupted temporal organization in the body, it is of importance to understand the processes involved 
in the synchronization of all body clocks and their phase relationship to the environmental day/night cycle at the mecha-
nistic level. This review will focus on internal and external factors affecting synchronization and function of the circadian 
system and highlight connections to mood-related behavior. 
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 Introduction 
Rotation of the earth around its own axis leads to 
periodic exposure of its surface to the sun causing 
day and night. Life-forms on this planet adapted to 
the rhythmic light/dark exposure that has a period of 
about 24 hours. Since this rhythm is predictable, it 
was beneﬁ cial for organisms to develop an internal 
timer in order to predict daily recurring events, such 
as appearance of a food source. Additionally, this 
internal clock enables organization of metabolism 
and the cell cycle according to the time of day to 
avoid incompatible biochemical reactions to run at 
the same time and to allocate such reactions to the 
time of day when they are needed most (e.g. energy 
production during the activity phase, repair mecha-
nisms during the rest phase). In order to assure a 
stable phase relationship between the natural light/
dark cycle and the internal timing system of organ-
isms, their clocks need to be reset daily, because the 
earth’s orbit around the sun causes periodic seasonal 
alterations of day-length leading to short winter days 
and long summer days. The strongest cue for the 
synchronization between natural daily cycles and the 
internal clock of animals and humans is light 
(reviewed in (1)). It is perceived by the retina, where 
specialized retinal ganglion cells (RGCs) containing 
melanopsin project directly via the retinohypotha-
lamic tract (RHT) to the suprachiasmatic nuclei 
(SCN), the main co-ordinator of the mammalian 
circadian system located in the ventral part of the 
hypothalamus (Figure 1). The SCN project to vari-
ous brain regions involved in hormone secretion (e.g. 
paraventricular nucleus), sleep regulation (ventrolat-
eral preoptic nucleus), thermoregulation (median 
preoptic region), and feeding/reward (e.g. dorsome-
dial hypothalamus) (reviewed in (2)). 
Light perceived by RGCs causes release of glu-
tamate at the synapses of the RHT and leads to acti-
vation of signaling pathways that converge on the 
phosphorylation of cyclic adenosine monophosphate 
(cAMP) response element-binding protein (CREB). 
Phospho-CREB homodimers bind to the promoters 
of the clock genes Per1 and Per2 thereby activating 
their expression (Figure 2). As a consequence behav-
ioral activity rhythms in mice and humans are phase 
advanced or delayed, depending on the time of noc-
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turnal light exposure. At the molecular level the 
autoregulatory feedback loop mechanism of the 
clock is altered in its phase, most probably because 
the Per genes are induced by light in the SCN (3,4). 
PER (period homolog) and CRY (cryptochrome) 
proteins heterodimerize in the cytoplasm and enter 
the nucleus to inhibit the activation potential of the 
heterodimeric complex composed of BMAL1/
CLOCK (brain and muscle aryl hydrocarbon recep-
tor nuclear translocator-like factor 1/circadian loco-
motor output cycles kaput) (or BMAL1/NPAS2 
(neuronal Per-Arnt-Sim [PAS] domain protein 2) in 
brain tissue) (Figure 2, reviewed in (5)). Otherwise 
this complex would activate transcription via binding 
to E-box elements present in the promoters of clock 
genes such as Per, Cry, Dec, and  Rev-erba or clock-
controlled genes (CCGs) such as monoamine oxidase 
A (MAOA) (6). PER and CRY proteins inhibit their 
own transcription via the aforementioned inhibition 
of the BMAL1/CLOCK complex thereby establishing 
an autoregulatory feedback loop. REV-ERB α protein 
represses the transcription of BMAL1 thereby linking 
the PER/CRY feedback loop with BMAL1 expression 
(7). The half-life of these clock proteins is an impor-
tant factor affecting the length of one feedback loop 
cycle. Casein kinase 1  ε/δ (CK1 ε/δ) phosphorylates 
the PER proteins thereby targeting them for degrada-
tion by the 26S proteasome (8,9).  In vitro studies sug-
gest that the  β-TrCP1 and FBXL3 E3 ubiquitin ligase 
complexes directly target PER (10,11) and CRY 
(12,13) proteins, respectively, for this degradation. 
Furthermore, SIRT1, an NAD -dependent deacety-
lase involved in transcriptional silencing, genome sta-
bility, and longevity (14), deacetylates PER2 which 
leads to its degradation (Figure 1) (15). 
In mammals, daily rhythms can be observed in 
body temperature, the sleep/wake cycle, hormone 
levels, cognition, attention, and mood (16). The 
cycling of these physiological markers has a stable 
phase relationship with the natural light/dark cycle. 
A disruption of this stable phase relationship by 
external factors such as rotating shift-work may lead 
to health problems (e.g. obesity and mood disorders). 
Hence life-style is an important factor in the mani-
festation of mood disorders. However, some people 
are more prone than others to develop such disor-
ders, indicating involvement of genetic (internal) fac-
tors. In addition to genes involved in metabolism and/
or the cell cycle, alterations in clock genes and their 
promoters appear to predispose humans to develop-
ment of mood disorders. This review will focus on 
the internal and external factors affecting synchroni-
zation and function of the circadian system and high-
light connections to mood related behaviors. 
External factors  
Predictable events–-light/dark cycle and sleep 
Light is the most powerful synchronizer of the mam-
malian circadian system (see Introduction). It causes 
expression of PER genes in the SCN and a few 
peripheral oscillators like the pineal and adrenal 
glands (3,17–19) (Figure 1). From these relays other 
tissue clocks are co-ordinated via hormonal secre-
tion, the autonomous nervous system, and indirectly 
Key messages 
• The circadian clock organizes biochemistry 
and physiology on a 24-hour time-scale. 
When this order is chronically disrupted 
health problems including mood disorders 
may occur. 
• Environmental factors inﬂ uence the circa-
dian system and might be causative for 
biochemical and physiological disorgani-
zation of the body. 
Abbreviations 
BMAL1 brain and muscle aryl hydrocarbon 
 receptor nuclear translocator-like 
 factor 1 
CCG clock-controlled gene 
CK1 casein kinase 1 
CLOCK circadian locomotor output cycles 
 kaput 
CREB cAMP response element-binding 
 protein 
CRY cryptochrome 
DSPS delayed sleep phase syndrome 
FASPS familial advanced sleep phase 
 syndrome 
GSK3β glycogen synthase kinase 3 β
IPSRT interpersonal and social rhythm 
 therapy 
MAOA monoamine oxidase A 
NPAS2 neuronal PAS domain protein 2 
NPY neuropeptide Y 
PER period homolog 
PK2 prokineticin 2 
RGC retinal ganglion cell 
RHT retinohypothalamic tract 
SAD seasonal affective disorder 
SCN suprachiasmatic nuclei 
SD sleep deprivation 
VIP vasoactive intestinal peptide 
VTA ventral tegmental area 
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via the regulation of the rest/activity cycle and with 
it body temperature and metabolic activity (20,21) 
(Figure 1). Due to these consequences of light on 
physiology and behavior, irregular light exposure, as 
experienced in shift-work and jet lag, has strong 
implications on physiology and behavior which 
manifest as health problems such as cardiovascular 
disease, cancer, and mood disorders (22). Therefore, 
regular periodic exposure to light appears to be 
beneﬁ cial for health, because it synchronizes the cir-
cadian system to maintain biochemical and physio-
logical order in the body. Interestingly, light therapy 
has been successfully used to treat mood disorders. 
This is especially true for seasonal affective disorder 
Figure 1. Pathways to synchronize the circadian system. The network of circadian clocks present in all cells and tissues is synchronized
with external time via neuronal and humoral pathways. A light signal perceived by the retina is mediated via the retinohypothalamic tract 
(RHT) to the suprachiasmatic nuclei (SCN) and affects clock gene expression. From the SCN the sleep (ventrolateral preoptic nucleus
(VLPO)) and arousal centers (locus coeruleus (LC)), endocrine tissues such as the pituitary (Pit) and the adrenal, and other peripheral 
tissues such as the kidneys and liver are synchronized via the autonomous nervous system. Rhythmically released hormones, ACTH from
the pituitary (Pit), melatonin from the pineal (Pin), and corticoids from the adrenal (A), further contribute to the synchronization of the 
circadian system. Additionally, other external factors such as food, stress, and systemic cues affect the circadian system. 
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(SAD) (23), also known as winter depression. SAD 
is a mood disorder in which people have normal 
mental health throughout most of the year, but expe-
rience depressive symptoms in winter or, less fre-
quently, in other seasons, repeatedly, year after year. 
SAD is more prevalent in countries of higher lati-
tude (e.g. Scandinavia, Canada) correlating with the 
extremely shortened daily light period during the 
winter season. SAD can be successfully treated in 
some cases with melatonin or by exposure to bright 
light; especially early morning light appears to be 
effective resulting in a phase advance of behavioral 
and endocrine rhythms (24,25). 
Light therapy is more and more frequently used 
in non-seasonal depression and bipolar disorder 
(26–28), either exclusively or in combination with 
other conventional treatments. A few data exist on the
efﬁ cacy of light exposure on schizophrenic patients. 
For example, irregular natural light exposure corre-
lates with disease severity (29), and light treatment, 
especially in the blue wavelength range that activates 
melanopsin-containing RGCs (see Introduction), 
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Figure 2. Transcriptional–translational feedback network constituting the mammalian circadian clock. A primary negative feedback loop 
involves the genes  Clock (protein abbreviated with C) and its paralog neuronal PAS domain protein 2,  Npas2 (protein abbreviated with N), 
Bmal1, the period homologs  Per1, Per2, and the cryptochromes  Cry1, Cry2. The secondary feedback loop is composed of  Rev-erba and 
retinoic acid receptor related orphan receptor (ROR) whose gene products bind ROR response elements (ROREs) in the  Bmal1 promoter 
and repress or activate this gene, respectively. In addition to transcriptional activators and repressors, post-translational modiﬁ cation and 
degradation of circadian clock proteins are crucial steps for determining circadian periodicity. Key kinases for PER and CRY phosphorylation 
are casein kinase 1 ε (CK1 ε) and CK1 δ. Phosphorylation of PER and CRY proteins leads to facilitated nuclear transport or alternatively 
targets them for polyubiquitination and degradation by the 26S proteasomal pathway involving the  β-TrCP1 and FBXL3 E3 ubiquitin ligase 
complexes. The output of this clock mechanism is the transcriptional regulation of clock-controlled genes (CCG) that mediate rhythmic 
biological processes. The autoregulatory feedback loop mechanism of the circadian clock can be adjusted to external events via activation 
of the CREB/MAPK (mitogen-activated protein kinase) signaling pathway that impinges on  Per gene regulation. Pharmacological agents 
such as lithium ions (Li ) can modulate clock protein stability and modulate the circadian cycle and associated biological processes. 
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can re-establish normal endocrine function in schizo-
phrenic patients (30). This is probably due to direct 
regulation of the SCN, which transmits the light 
signal to activate the adrenals (18) (Figure 1). Corti-
costeroids from the adrenal have a strong feedback 
effect on neurophysiological functions in the central 
nervous system (CNS) (31). However, the molecular 
mechanisms through which light causes the alleviat-
ing effects on mood disorders are not understood. 
Recent ﬁ ndings indicate that light-mediated sig-
naling involving the clock gene  Per2 affects synaptic 
efﬁ ciency in mice by regulating the presence of vesic-
ular glutamate transporter 1 on a deﬁ ned vesicular 
pool (32,33). The light-regulated membrane trafﬁ c 
of neurotransmitter transporters may allow the pre-
synaptic terminals to replenish during physiological 
rest periods and to avoid prolonged or repeated peri-
ods of enhanced stimulation. This is probably one of 
several reasons why mice bearing a mutation in the 
Per2 gene show alterations in mood-related behav-
iors (6,34,35). Proteomic analysis revealed that syn-
aptic vesicle cycling itself is probably important for 
sustaining the circadian clock in the SCN (36). This 
is supported by the ﬁ nding that mice with a mutation 
in the GTPase Rab3, a regulator of synaptic vesicle 
transport and Ca 2-triggered vesicle release proba-
bility, accelerates the clock by about 2 hours (37). 
Taken together synaptic vesicles appear to play an 
important role in light-mediated effects on the circa-
dian clock and its neurophysiological outputs. 
Mood disorders are strongly associated with sleep 
disturbance (38–41). Sleep is regulated by two differ-
ent mechanisms, a homeostatic one that accumulates
the need for sleep depending on the time spent 
awake (like an hour-glass counter), and a rhythmic 
one controlled by the circadian clock in the SCN 
that under normal conditions conﬁ nes sleep to the 
night in humans (or day in nocturnal animals like 
mice) (42). Therefore, it is reasonable to assume that 
the circadian clock, the sleep/wake cycle, and the 
interaction between the two may play a role in the 
pathophysiology of mood disorders. In support of 
this view is the ﬁ nding that sleep deprivation (SD) 
can have antidepressant effects and, in susceptible 
patients, precipitate mania (43). Hence it appears 
that sleep/wake disruption can play a causal role in 
mood disorders. If the protocol for SD is stopped, 
relapse of depressive symptoms is observed. SD 
serves as a strong external signal, which might lead 
to synchronization of various oscillators. If SD is not 
maintained, gradually desynchronization of various, 
weakly coupled oscillators in different brain regions 
can occur, ultimately contributing to depressive 
symptoms. At the cellular level temporal synchroni-
zation of the circadian clock in ﬁ broblasts is achieved 
in vitro by a serum shock or the glucocorticoid 
analog dexamethasone (44,45). Omission of these 
external signals for the cell culture leads to a gradual 
desynchronization of the circadian clocks in the 
individual cells. Similar to a serum shock inducing 
synchronized rhythmic clock gene expression in 
ﬁ broblasts, SD can temporally stabilize rhythmic 
cortisol release from the adrenal in depressive 
patients but has no effect in the control group (46). 
However, it is not clear whether SD directly acts on 
the clock mechanism as a synchronizing signal. 
Metabolism and/or the cell cycle, which both are 
intimately linked to the clock (Figure 3), might be 
affected by SD. Hence, SD would act on mood either 
via modulation of the circadian clock and/or via 
metabolism and the cell cycle. 
Unpredictable events—social and non-social stress 
The circadian clock’s function is to maintain a stable 
phase relationship between endogenous rhythms 
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Figure 3. Model illustrating the relationship between internal/external factors and mood status according to the degree of desynchroni-
zation between the internal and external worlds. 
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and the predictable light/dark cycle and is an adap-
tation to predictable aspects of the environment 
(see Introduction). However, the stress system that 
acts on the autonomous nervous system is an adap-
tation to unpredictable aspects of the environment 
(47). Experiments in rodents illustrate that social as 
well as non-social stress alter the shape and ampli-
tude of a circadian rhythm but do not perturb the 
central oscillator in the SCN. In line with these ﬁ nd-
ings are experiments showing that manipulation of 
the main neuroendocrine components of the stress 
system does not have any major effect on the circa-
dian clock (reviewed in (48)). However, circadian 
rhythms at the output level are strongly affected by 
stress. For example, the synthetic glucocorticoid 
dexamethasone alters rhythmic gene expression in 
cell cultures from liver, kidney, and heart tissue, 
even though it does not affect gene expression in 
neurons of the SCN (45). However,  in vivo gluco-
corticoid treatment does not have a strong effect on 
free-running temperature and activity rhythms 
(49,50), but it cannot be excluded that glucocorti-
coids affect other rhythms that are under partial 
control of sub-oscillators. It may also be that such 
sub-oscillators in peripheral tissues are affected by 
stress factors other than glucocorticoids. It may be 
speculated that certain stress factors affect oscilla-
tors in peripheral tissues such as the liver and kidney 
(Figure 1), temporarily disturbing their control by 
the central pace-maker clock in the SCN, which 
may then be partly responsible for disturbed overt 
rhythms seen, for instance, after social defeat stress. 
Chronic stress might lead to a permanent desyn-
chronization of the light-sensitive pace-maker in 
the SCN and the clocks in peripheral tissues, ren-
dering the organism susceptible to the development 
of diseases affecting mood. 
Stress-mediated desynchronization of periph-
eral clocks in patients with bipolar disorder can be 
successfully treated with interpersonal and social 
rhythm therapy (IPSRT) along with pharmacologi-
cal treatment (reviewed in (51)). This therapy helps 
patients to see how psycho-social stressors and social 
role transitions can disrupt the daily routines that are 
important to maintain the circadian integrity of the 
body. Hence, IPSRT reduces stress inﬂ uence via 
the autonomic nervous system and reinforces daily 
routine. As a result peripheral clocks are probably 
aligned with the day/night cycle and the central clock 
in the SCN, increasing biochemical and physio-
logical order in the entire organism. 
The 24-hour society, as we know it today, is 
strongly inﬂ uenced by the aberrant occurrence of 
the external parameters light, sleep deprivation, and 
stress. Due to the constant access to electricity and 
hence artiﬁ cial light, the activity of individuals has 
gradually shifted into the night period that naturally 
would be used for rest and sleep (52). The conse-
quence is accumulation of a sleep deﬁ cit, forcing 
people to sleep at unusual times. This may lead to 
deprivation of naturally occurring external signals, 
further enhancing desynchronization between the 
organism and nature. The result is a ‘social jet lag’. 
Since natural external signals still can inﬂ uence 
the desynchronized organism, at certain times a 
permanent adaptation is the consequence, with the 
organism permanently trying to align the internal 
and external worlds. The constant access to light 
also affects interpersonal relationships and social 
roles due to work and stress at unusual times, which 
leads to a desynchronization of peripheral clocks. 
Primed by such desynchronization the organism 
becomes hypersensitive to stressful life events, 
such as death of a beloved person or other traumatic 
incidents, triggering development of mood disor-
ders (53). Hence, several incidents accumulate 
and together increase the amount of desynchrony 
ultimately affecting the degree of a mood disorder 
(Figure 3) (54). 
Internal factors—clock components 
impinging on mood 
Neurological and behavioral phenotypes 
of clock gene mutations in rodents 
Given the fact that clock genes are expressed in 
various brain areas with different phases (55), an 
impact of clock genes on brain function can be 
expected. Deﬁ cits in brain function could be due to 
a disturbance in SCN oscillator function or ham-
pered oscillator function in discrete brain areas; 
alternatively, they might be a secondary consequence 
of neuronal dysfunction. 
Mutations in the genes  Clock, Bmal1, Cry1, and 
Cry2 result in altered sleep time, sleep fragmenta-
tion, and atypical responses after sleep deprivation 
in mice (56–58). Elements of sleep homeostasis 
are also affected in mice mutant in a number of 
other clock-related genes including  Npas2, Dec2,
Dbp, and  Pk2 (59–62). However, evidence exists for 
a functional segregation of circadian and homeo-
static parameters of sleep, because mutations in 
Per1 and  Per2 cause no effects on the sleep homeo-
static mechanism, although robust rhythms of sleep 
and wakefulness are affected under constant condi-
tions (63,64). Taken together, these data indicate 
that clock genes have an effect on allocation of sleep 
time; however, only a subset of clock genes appears 
to affect the homeostat. This is probably due to 
indirect effects of clock genes on metabolism and 
neuronal function. 
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As already discussed above, a desynchronized 
circadian system affects emotional behavior. Mice 
mutant in the gene Clock expressing a dominant 
negative version of the CLOCK protein exhibit a 
spectrum of behavioral abnormalities, including low 
anxiety, mania, and hyperactivity (65,66). Further-
more, deregulation of important neurotransmitters 
such as neuropeptide Y (NPY) or vasoactive intesti-
nal peptide (VIP), which are involved in signaling 
to and within the SCN, leads to alterations in anxi-
ety-like behavior and aggression (67–69). Lithium, 
a mood-stabilizing agent, can reverse behavioral 
disturbances observed in  Clock-mutant mice (66), 
indicating that the therapeutic effects of lithium may 
be partly mediated via the circadian system. This 
hypothesis is bolstered by the ﬁ nding that lithium is 
a potent inhibitor of glycogen synthase kinase 3 β
(GSK3β), a kinase that inﬂ uences the nuclear 
expression and stability of a number of transcription 
factors and circadian clock proteins including 
REV-ERB α and PER2 (70–72) (Figure 2). How-
ever, it is unclear whether the lithium doses used for 
therapeutic treatment in humans are sufﬁ cient to 
inhibit human GSK3 β. In mice, the clock proteins 
BMAL1, NPAS2, and PER2 regulate the expression 
levels and activity of monoamine oxidase A (MAOA), 
an enzyme important in the degradation of dop-
amine (and other catecholamines) (6). In this mech-
anism PER2 acts as a co-activator and modulates 
dopamine levels in the mesolimbic dopaminergic 
system. This has an impact on mood-related behav-
ior in mice, leading to the conclusion that the clock 
can inﬂ uence mood. In support of this view is that 
SAD in humans correlates with the frequency of spe-
ciﬁ c single-nucleotide polymorphisms in  BMAL1,
NPAS2, and  PER2 (73). Based on the ﬁ nding that 
the circadian clock regulates dopamine metabolism 
and in view of the fact that PER2 interacts with 
GSK3β (70), it was proposed that PER2 phospho-
rylation by GSK3 β favors accumulation of PER2 in 
the nucleus where it enhances the NPAS2:BMAL1-
mediated transcription of monoamine oxidase A 
(Maoa) (74). As a consequence more MAOA enzyme 
would be generated and translocated to the inner 
mitochondrial membrane. There, MAOA degrades 
dopamine, producing 3,4-dihydroxyacetaldehyde, 
peroxide, and ammonia. Increased levels of PER2 
might therefore lead to less dopamine and a more 
depressed mood state (75,76). The mood stabilizer 
lithium inhibits the action of GSK3 β, and less PER2 
would be phosphorylated (70). As a consequence, 
PER2 would become less abundant in the nucleus, 
which would lead to less MAOA production. Con-
sequently, dopamine would rise and improve mood 
status. This might be a potential mechanism explain-
ing the beneﬁ cial effects of lithium on mood. In line 
with the notion that clock genes inﬂ uence mood 
through modulation of dopamine are the observa-
tions that  Clock-mutant mice display an increase in 
dopaminergic activity in the ventral tegmental area 
(VTA) and that restoration of  Clock expression in the 
VTA rescues some of the mood-related behavioral 
abnormalities (66,77). Of note is, however, that 
more dopamine (or dopaminergic activity) does not 
always correlate with an improvement of mood sta-
tus. Mice that have been subjected to a chronic social 
defeat paradigm, which leads to a strong depression-
like state, show an increase in dopaminergic activity 
in the VTA, while mice resistant to this paradigm 
display no change (78). 
An alternative to lithium in treating depression 
is bright light therapy (see above), which has been 
successfully used for recurrent winter depression 
or SAD (23). Clock genes, especially  Per1 and  Per2,
are inducible by light in the SCN (4). However, it 
is not known how this might relate to the relief of 
depressive episodes. One possibility is that light 
affects the habenula, which receives direct light 
input from the retina (79). The clock genes  Per1 
and Per2 in the habenula might be induced by light 
leading to alterations in the function of the mesolim-
bic dopaminergic system, thought to be modulated 
by this brain region (80). Interestingly, a recent 
study in Drosophila shows that dopamine plays an 
important role in circadian entrainment reinforcing 
a connection between light signaling to the clock 
and dopamine (81). 
Polymorphisms in genes of the circadian clock 
and mood disorders in humans 
In many CNS disorders, disturbance of circadian 
rhythms and sleep is part of the clinical characteriza-
tion of the disease. Such clock and sleep disruptions 
are probably secondary to compromised neuronal 
circuitry when brain regions regulating output 
rhythms are affected. In any case, it is difﬁ cult to 
dissect whether disruptions in the circadian clock 
are a cause or a consequence of CNS disorders. 
However, it is very likely that disruption of circadian 
oscillators can at least modify disease severity and 
that, in some cases, it might play a more primary role 
in disease etiology. 
Mice mutant in clock genes often display altera-
tions in the period length of the circadian rhythm 
leading to alterations in sleep onset. Therefore, one 
would predict that also in the human population 
such alterations in period length would be associated 
with sleep onset caused by variants of genes involved 
in the circadian clock mechanism. So far, the best 
understood familial syndrome hinting at a direct 
involvement of the circadian clock in early sleep 
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onset is the familial advanced sleep phase syndrome 
(FASPS). This disorder is characterized by very early 
sleep on- and offset. Affected individuals show a pro-
found phase advance of melatonin and temperature 
rhythms associated with a very short period length 
and variable degrees of depression (82). Since the 
trait segregates in an autosomal dominant manner 
with high penetrance, the genes affected in such 
families could be identiﬁ ed. In one family, the casein 
kinase 1 ε (CK1 ε) binding site in the gene product 
of PER2 was mutated, which causes hypophospho-
rylation of the PER2 protein (83). A missense muta-
tion in CK1d that decreases the enzymatic activity of 
CK1δ also leads to hypophosphorylation of PER2 
(Figure 2) and FASPS (84). 
To identify associations between the circadian 
clock and human disease, clock gene polymor-
phisms were studied in patients and healthy people. 
A polymorphism in the  Clock gene did associate 
with delayed sleep phase syndrome (DSPS) (85). 
A silent polymorphism in the  PER1 gene did asso-
ciate with extreme diurnal preference (86), as did 
a structural polymorphism in the  PER3 gene (87). 
A shorter 4-repeat allele of a 54-base-pair coding-
region polymorphism in  PER3 appears to be associ-
ated with DSPS (88), and this polymorphism 
predicts sleep structure and waking performance 
(89). Interestingly, polymorphisms in various clock 
genes do not only affect sleep-associated pheno-
types. A single nucleotide polymorphism in  CLOCK
appears to bias neural correlates of moral valence 
decision in depressed patients (90), and other 
genetic variants of this gene are associated with 
individual susceptibility to obesity (91). The  NPAS2
gene has been associated with seasonal affective 
disorder (92) as well as the genes  BMAL1 and 
PER2 (73). Furthermore,  BMAL1 variants appear 
to be associated with susceptibility to hypertension 
and type 2 diabetes (93), and  PER2 variation is 
associated with depression vulnerability (94). There 
is also evidence that single nucleotide polymor-
phisms in retinoic acid receptor-related orphan 
receptor (ROR) beta are associated with bipolar 
disorder (95). For  CRY1, an involvement in schizo-
phrenia has been suggested, because it is close to 
a linkage hot spot of this disease and interacts 
with antipsychotic drugs and the dopamine system 
(96). However,  CRY1 appears not to be involved in 
bipolar disorder (97). 
The association of clock gene polymorphisms 
with mood disorders strongly suggests that clock 
genes may be important candidates in the search for 
the molecular basis of mood disorders. In the future, 
systematic studies in both humans and animals will 
uncover the contribution of clock gene variants to 
the onset and severity of mood disorders. 
Conclusions
The inﬂ uence of external (light, SD, stress) and 
internal factors (genetic alterations) on mood-related
behaviors has been extensively studied. The inter-
play between external and internal factors and 
their concerted action in relation to mood is, how-
ever, poorly understood. Therefore, future studies 
need to aim at the elucidation of mechanisms 
that connect the effects of external factors on inter-
nal mechanisms to understand, for example, how 
light or lithium therapy is beneﬁ cial for certain 
mood disorders at the mechanistic level. These 
studies will have the potential to suggest novel ther-
apeutic approaches, both pharmacological and non-
pharmacological. This provides one of the best 
opportunities in psychiatry today for translational, 
bench-to-bedside research. 
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